Maraviroc

Maraviroc is an antiviral medication currently still under a patent owned by Pfizer. It is one of the antivirals that is recommended by the FLCCC and Bruce Patterson's IncellDx for the treatment of long covid. Therefore, it may also be of use in curing ME/CFS.

Sources:

https://covid19criticalcare.com/wp-content/uploads/2020/12/FLCCC-Protocols-%E2%80%93-A-Guide-to-the-Management-of-COVID-19.pdf page 22

https://www.businesswire.com/news/home/20211123005960/en/IncellDx-Awarded-Patent-for-Use-of-CCR5-Antagonist-Maraviroc-in-Treatment-of-COVID-19

Patterson B, Yogendra R, Guevara-Coto J, Osgood E, Bream J, Parikh P. Targeting the monocytic-endothelialplatelet axis with maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae